Glenmede Trust’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-419
Closed -$16K 2415
2020
Q3
$16K Buy
419
+23
+6% +$743 ﹤0.01% 1706
2020
Q2
$12K Buy
396
+98
+33% +$3.66K ﹤0.01% 1805
2020
Q1
$14K Hold
298
﹤0.01% 2274
2019
Q4
$14K Buy
298
+103
+53% +$4.69K ﹤0.01% 2274
2019
Q3
$9K Buy
195
+74
+61% +$3.48K ﹤0.01% 2412
2019
Q2
$5K Buy
+121
New +$4.7K ﹤0.01% 2656
2018
Q2
Sell
-210
Closed -$4K 2391
2018
Q1
$4K Hold
210
﹤0.01% 2480
2017
Q4
$4K Sell
210
-10,982
-98% -$277K ﹤0.01% 2480
2017
Q3
$315K Sell
11,192
-11,437
-51% -$348K ﹤0.01% 1061
2017
Q2
$639K Hold
22,629
﹤0.01% 878
2017
Q1
$639K Buy
+22,629
New +$601K ﹤0.01% 878
2016
Q1
Sell
-117
Closed -$1K 2741
2015
Q4
$1K Sell
117
-120
-51% -$1.78K ﹤0.01% 2587
2015
Q3
$3K Hold
237
﹤0.01% 2441
2015
Q2
$6K Hold
237
﹤0.01% 2210
2015
Q1
$9K Hold
237
﹤0.01% 2152
2014
Q4
$7K Hold
237
﹤0.01% 2271
2014
Q3
$5K Buy
237
+123
+108% +$3.5K ﹤0.01% 2243
2014
Q2
$3K Sell
114
-114
-50% -$3.29K ﹤0.01% 2225
2014
Q1
$7K Buy
228
+78
+52% +$2.58K ﹤0.01% 2111
2013
Q4
$5K Buy
+150
New +$4.36K ﹤0.01% 2130

Other funds holding CSII

Glenmede Trust's CSII Position: Q4 2020 in Review

Glenmede Trust sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2020, closing a stake of 419 shares — an estimated $16K sold.

Glenmede Trust first reported a position in CSII in Q4 2013 and held it in 20 quarters. The position peaked at $639K in Q2 2017. 183 funds tracked by Wall St. Rank hold CSII as of Q4 2020.

  • Glenmede Trust reported no remaining Cardiovascular Systems, Inc. position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 419 Cardiovascular Systems, Inc. shares in Q4 2020, an estimated $16K.
  • Glenmede Trust first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 20 quarters.
  • Glenmede Trust's Cardiovascular Systems, Inc. position peaked at $639K in Q2 2017.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.